These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. The interaction of norepinephrine and prostaglandin E1 on the adenyl cyclase system of human and rabbit blood platelets. Moskowitz J; Harwood JP; Reid WD; Krishna G Biochim Biophys Acta; 1971 Feb; 230(2):279-85. PubMed ID: 4324760 [No Abstract] [Full Text] [Related]
44. Effects of indomethacin on cyclic nucleotide levels and histamine release from rat serosal mast cells. Lewis RA; Holgate ST; Roberts LJ; Maguire JF; Oates JA; Austen KF J Immunol; 1979 Oct; 123(4):1663-8. PubMed ID: 90096 [No Abstract] [Full Text] [Related]
45. [Metabolism and functions of prostaglandin D2 in the brain and blood platelets]. Shimizu T Seikagaku; 1982; 54(7):419-34. PubMed ID: 6815286 [No Abstract] [Full Text] [Related]
46. Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human platelets. Malmsten C; Granström E; Samuelsson B Biochem Biophys Res Commun; 1976 Jan; 68(2):569-76. PubMed ID: 175797 [No Abstract] [Full Text] [Related]
47. Prostaglandins as intracellular messengers. Silver MJ; Smith JB Life Sci; 1975 Jun; 16(11):1635-48. PubMed ID: 167250 [No Abstract] [Full Text] [Related]
49. [Regulation of blood platelet function by cyclic nucleotides and prostaglandins]. Hynie S; Hynieová H Cesk Fysiol; 1982; 31(1):1-12. PubMed ID: 6277520 [No Abstract] [Full Text] [Related]
50. Specific leukocyte receptors for small endogenous hormones. Detection by cell binding to insolubilized hormone preparations. Weinstein Y; Melmon KL; Bourne HR; Sela M J Clin Invest; 1973 Jun; 52(6):1349-61. PubMed ID: 4145025 [TBL] [Abstract][Full Text] [Related]
51. [Lipid mediators in inflammation (essential fatty acids, prostaglandins and leukotrienes) in dermatology]. Meynadier J; Michel B Ann Dermatol Venereol; 1983; 110(10):851-60. PubMed ID: 6320709 [No Abstract] [Full Text] [Related]
52. Prostaglandins in normal and pathological skin. Sondergaard J J Cutan Pathol; 1974; 1(6):275-90. PubMed ID: 4470730 [No Abstract] [Full Text] [Related]
53. Effects of epoxymethano analogues of prostaglandin endoperoxides on aggregation, on release of 5-hydroxytryptamine and on the metabolism of 3',5'-cyclic AMP and cyclic GMP in human platelets. Best LC; McGuire MB; Martin TJ; Preston FE; Russell RG Biochim Biophys Acta; 1979 Mar; 583(3):344-51. PubMed ID: 221045 [No Abstract] [Full Text] [Related]
54. Rat osteogenic sarcoma cells: isolation and effects of hormones on the production of cyclic AMP and cyclic GMP. Atkins D; Hunt NH; Ingleton PM; Martin TJ Endocrinology; 1977 Aug; 101(2):555-61. PubMed ID: 195798 [No Abstract] [Full Text] [Related]
55. The role of cyclic AMP in the chemotactic responsiveness and spontaneous motility of rabbit peritoneal neutrophils. The inhibition of neutrophil movement and the elevation of cyclic AMP levels by catecholamines, prostaglandins, theophylline and cholera toxin. Rivkin I; Rosenblatt J; Becker EL J Immunol; 1975 Oct; 115(4):1126-34. PubMed ID: 170335 [TBL] [Abstract][Full Text] [Related]
57. Effects of prostaglandins on function and cyclic AMP levels of human blood platelets. Robison G; Cole B; Arnold A; Hartmann R Ann N Y Acad Sci; 1971 Apr; 180():324-31. PubMed ID: 4329031 [No Abstract] [Full Text] [Related]
58. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets. Ashby B Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318 [TBL] [Abstract][Full Text] [Related]
59. Cyclic nucleotides and prostaglandins in psoriasis. Raab WP Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):212-24. PubMed ID: 6248471 [TBL] [Abstract][Full Text] [Related]
60. [Leukotrienes and other products of lipoxygenases. Nature and biological profile]. Gimeno AL Acta Physiol Pharmacol Latinoam; 1985; 35(1):67-92. PubMed ID: 2998154 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]